Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

novartis ag - NVS

NVS

Close Chg Chg %
132.36 0.21 0.15%

Closed Market

132.57

+0.21 (0.15%)

Volume: 1.23M

Last Updated:

Dec 12, 2025, 3:59 PM EDT

Trade Now

Company Overview: novartis ag - NVS

NVS Key Data

Open

$132.36

 Day Range

131.78 - 133.01

52 Week Range

96.06 - 134.24

 Market Cap

$248.94B

Shares Outstanding

1.90B

 Public Float

1.90B

Beta

0.51

 Rev. Per Employee

N/A

P/E Ratio

17.92

 EPS

$7.38

Yield

247.59%

 Dividend

$3.28

EX-DIVIDEND DATE

Mar 12, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.80M

  

NVS Performance

No Data Available

NVS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 29
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Novartis Ag - NVS

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
51.63B 50.64B 45.60B 50.29B
Sales Growth
+5.47% -1.90% -9.95% +10.28%
Cost of Goods Sold (COGS) incl D&A
15.87B 15.34B 12.62B 12.81B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.43B 5.46B 8.31B 6.07B
Depreciation
1.53B 1.47B 1.27B 1.19B
Amortization of Intangibles
3.90B 3.99B 7.03B 4.88B
COGS Growth
+4.31% -3.35% -17.72% +1.50%
Gross Income
35.76B 35.31B 32.98B 37.48B
Gross Income Growth
+5.99% -1.26% -6.58% +13.63%
Gross Profit Margin
+69.27% +69.72% +72.33% +74.53%
2021 2022 2023 2024 5-year trend
SG&A Expense
24.43B 23.18B 20.87B 22.06B
Research & Development
9.54B 8.90B 8.25B 9.51B
Other SG&A
14.89B 14.28B 12.61B 12.56B
SGA Growth
+6.39% -5.09% -9.99% +5.74%
Other Operating Expense
- (269.00M) (162.32M) 209.75M
Unusual Expense
684.00M 4.51B 3.61B 1.92B
EBIT after Unusual Expense
10.92B 7.77B 8.29B 13.49B
Non Operating Income/Expense
785.00M 1.66B 1.75B 1.21B
Non-Operating Interest Income
71.00M 379.74M 629.24M 567.68M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
905.00M 1.03B 876.12M 1.04B
Interest Expense Growth
-2.32% +14.14% -15.19% +18.30%
Gross Interest Expense
909.00M 1.04B 879.13M 1.04B
Interest Capitalized
4.00M 5.01M 3.01M 5.00M
Pretax Income
10.80B 8.40B 9.17B 13.67B
Pretax Income Growth
+16.61% -22.24% +9.20% +49.10%
Pretax Margin
+20.92% +16.58% +20.11% +27.18%
Income Tax
2.12B 1.42B 552.97M 1.70B
Income Tax - Current - Domestic
958.00M 618.20M 1.14B 896.49M
Income Tax - Current - Foreign
1.47B 1.46B 1.29B 1.49B
Income Tax - Deferred - Domestic
(23.00M) 142.28M (356.27M) 244.86M
Income Tax - Deferred - Foreign
(286.00M) (798.55M) (1.53B) (926.48M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
24.02B 6.97B 8.60B 11.93B
Minority Interest Expense
- (3.00M) 4.01M (2.00M)
Net Income
24.02B 6.97B 8.60B 11.93B
Net Income Growth
+195.82% -70.99% +23.39% +38.79%
Net Margin Growth
+46.53% +13.76% +18.86% +23.73%
Extraordinaries & Discontinued Operations
- - - 6.30B
-
Discontinued Operations
- - - 6.30B
-
Net Income After Extraordinaries
24.02B 6.97B 14.90B 11.93B
Preferred Dividends
- - - -
-
Net Income Available to Common
24.02B 6.97B 14.90B 11.93B
EPS (Basic)
10.7112 3.1949 7.176 5.9131
EPS (Basic) Growth
+200.35% -70.17% +124.61% -17.60%
Basic Shares Outstanding
2.24B 2.18B 2.08B 2.02B
EPS (Diluted)
10.6288 3.1719 7.1239 5.8645
EPS (Diluted) Growth
+200.53% -70.16% +124.59% -17.68%
Diluted Shares Outstanding
2.26B 2.20B 2.09B 2.04B
EBITDA
17.03B 17.74B 20.22B 21.48B
EBITDA Growth
-2.04% +4.18% +13.94% +6.27%
EBITDA Margin
+32.99% +35.04% +44.33% +42.72%

Novartis Ag in the News